The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

An FDA-cleared predictive analytic tool for hemodynamic instability may soon leverage its success in critical care to the ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

The FDA has included more information about the risk of myocarditis on the label for the Pfizer and Moderna COVID-19 vaccines.

The mental health industry watchdog Citizens Commission on Human Rights International (CCHR) is calling for sweeping reforms ...

Pharmaceutical companies spend $6 billion each year on direct-to-consumer ads, with every dollar spent netting more than $4 ...

When inflation and interest rates ticked upwards in the wake of Covid, the investment environment changed and share prices collapsed. That creates an opportunity for smart investors, says Jamie Ward ...

Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...